Related Experiment Video
Updated: Aug 24, 2025

06:35
A Scalable, Cell-Based Method for the Functional Assessment of Ube3a Variants
Published on: October 10, 2022
2.1K
A Scalable, Cell-based Method for the Functional Assessment of Ube3a Variants
1Department of Neuroscience, Washington University School of Medicine.
Journal of Visualized Experiments : Jove
|October 25, 2022
Summary
This study introduces a new cell-based assay to rapidly assess the impact of UBE3A gene variants on protein activity. This method helps understand neurodevelopmental disorders like autism and Angelman syndrome.
Area of Science:
- Genetics
- Neurobiology
- Biochemistry
Background:
- Millions of human genome coding variants are identified through sequencing.
- The functional significance of most variants, especially in neurodevelopmental disorder genes like UBE3A, remains largely unknown.
- UBE3A gene variants are linked to autism and Angelman syndrome, making their functional impact critical.
Purpose of the Study:
- To develop a rapid, cell-based assay for evaluating UBE3A variants.
- To determine the valence and magnitude of activity changes for UBE3A variants.
- To generate structure-function information for UBE3A to understand its enzymatic mechanisms.
Main Methods:
- A cell-based assay was developed by pairing UBE3A variants with a Wnt pathway reporter.
- The assay is designed to be rapid, scalable, and simple to use.
- This method allows for the assessment of UBE3A variant activity.
Main Results:
- A new protocol for studying UBE3A variants is described.
- The assay can determine the valence and magnitude of activity changes in any UBE3A variant.
- The method facilitates the generation of structure-function information for UBE3A.
Conclusions:
- The described assay provides a valuable tool for understanding the functional significance of UBE3A variants.
- This research offers insights into the enzymatic mechanisms of UBE3A.
- The findings are crucial for understanding neurodevelopmental disorders associated with UBE3A.

